Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare Biotechnology

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > New indication for PEA phase 2 coming soon

<< Previous

Bullboard Posts

Next >>

Comment by JAKPUG4LIFEon Nov 09, 2021 1:35pm

40 Views

Post# 34105684

RE:RE:RE:RE:RE:RE:New indication for PEA phase 2 coming soon

Time has told us already that anything you speak of is of promotion only and not facts. New investors beware

DavidRosenberg wrote:
DavidRosenberg wrote:

Mil_Man54 wrote: Oh right the paid PR video where th interviewer is provided the quesitons to ask the CEO....we have seen these before and you have been the interviewer yourself a few times....these videos have never been a reliable source of information...promises made ...promises broken would be the most apt descriptor of the videos...strictly for PR hype.

DavidRosenberg wrote:

Mil_Man54 wrote: Where did you source this information from?.....

DavidRosenberg wrote: New indications for PEA drug molecule coming soon for FSD Pharma phase 2

FSD Pharma; Agreement Signed With Covar Pharmaceuticals to Support the Development of Lucid PSYCH - YouTube

In that latest video Anthony Durkacz mentioned they will be making an annoucement shortly and that they have two potential indications for phase 2 but wil be choosing one and annoying their decision shortly for phase 2 for PEA !!!!!!!!

You are completely 10000% wrong because Anthony is leading the company now. He has alot of skin in the game. PR videos are ways that EVERY company does updates to shareholders and markets and analysts this is needed.

So please spare me that nonsense that you just described, Spoken like a true shortseller basher.

So you are saying updates from the company going forward are not true?

I guess time will tell if they are able too achieve IND's in 2022 for their 2 new drugs

and i guess time will tell if they submit new INDICATION for PEA for phase 2 trials ;)